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Abstract
Background: Alterations in muscarinic receptor expression and acetylcholinesterase (AchE) activity have been observed in
tissues from Sudden Infant Death Syndrome (SIDS). Vagal overactivity has been proposed as a possible cause of SIDS as well
as of vasovagal syncopes. The aim of the present study was to seek whether muscarinic receptor overexpression may be the
underlying mechanism of vagal hyperreactivity. Rabbits with marked vagal pauses following injection of phenylephrine
were selected and crossed to obtain a vagal hyperreactive strain. The density of cardiac muscarinic receptors and
acetylcholinesterase (AchE) gene expression were assessed. Blood markers of the observed cardiac abnormalities were also
sought.
Methodology/Principal Findings: Cardiac muscarinic M2 and M3 receptors were overexpressed in hyperreactive rabbits
compared to control animals (2.3-fold and 2.5-fold, respectively) and the severity of the phenylephrine-induced bradycardia
was correlated with their densities. A similar overexpression of M2 receptors was observed in peripheral mononuclear white
blood cells, suggesting that cardiac M2 receptor expression can be inferred with high confidence from measurements in
blood cells. Sequencing of the coding fragment of the M2 receptor gene revealed a single nucleotide mutation in 83% of
hyperreactive animals, possibly contributing for the transcript overexpression. Significant increases in AchE expression and
activity were also assessed (AchE mRNA amplification ratio of 3.6 versus normal rabbits). This phenomenon might represent
a compensatory consequence of muscarinic receptors overexpression. Alterations in M2 receptor and AchE expression
occurred between the 5th and the 7th week of age, a critical period also characterized by a higher mortality rate of
hyperreactive rabbits (52% in H rabbits versus 13% in normal rabbits) and preceeded the appearance of functional disorders.
Conclusions/Significance: The results suggest that cardiac muscarinic receptor overexpression plays a critical role in the
development of vagal hyperreactivity, whereas AchE hyperactivity appears as a compensatory consequence of it. Since
similar vagal disorders were observed recently by us in SIDS, muscarinic receptor overexpression could become a marker of
risk of vasovagal syncopes and SIDS.
Citation: Livolsi A, Niederhoffer N, Dali-Youcef N, Mokni W, Olexa-Zorn C, et al. (2010) Constitutive Overexpression of Muscarinic Receptors Leads to Vagal
Hyperreactivity. PLoS ONE 5(12): e15618. doi:10.1371/journal.pone.0015618
Editor: Naj Sharif, Alcon Research, Ltd, United States of America
Received August 17, 2010; Accepted November 15, 2010; Published December 22, 2010
Copyright:  2010 Livolsi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish,
or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: pascal.bousquet@unistra.fr
Introduction
We have recently reported alterations in muscarinic receptor
expression and acetylcholinesterase (AchE) activity in tissues from
Sudden Infant Death Syndrome (SIDS) [1], a syndrome for which
vagal overactivity has been proposed as a potential risk factor [2].
Vagal overactivity has been proposed as a possible cause of
vasovagal syncopes [3,4,5], which remain a challenge in many
patients, in particular infants and young athletes, and account for
1-2% of all emergency department visits [6,7]. Vasovagal syncope
has a lifetime cumulative influence of 35% and the frequency of
syncope in students ranges from 20 to 50% [8,9]; it may be
involved in sudden death, not only in newborns as stated above,
but also in young athletes [10,11].
Therefore, vagal overactivity appears as a possible common
cause of various pathological processes. Muscarinic receptor
overexpression, as we described in SIDS, could be a key factor
for the development of vagal overactivity.
We previously described an animal model of vagal hyperreac-
tivity [12]. In the present study, we used this rabbit model to
explore the pathogenesis of vagal hyperreactivity. As in SIDS, the
density of muscarinic receptors as well as AchE expression were
increased in the hearts of hyperreactive rabbit. Seeking blood
markers, we found that lymphocytes and heart exhibited the same
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e15618cholinergic abnormalities. In addition, we describe the evolution
over age of the biochemical features observed in lymphocytes.
Materials and Methods
Animals and in vivo experiments
The experimental rabbit model of vagal hyperreactivity has
been described previously [12]. Data obtained in hyperreactive (H)
animals (12–14 weeks old) were compared to those obtained in
age-matched normal (N) rabbits.
Maximal R-R interval was used to assess the baroreflex function
in conscious animals. We therefore measured the duration of the R-
R interval on ECG recording after injection of given dose of
phenylephrine (PNE) (500 mgk g
21) into the marginal ear vein as
described previously [12]. Maximal R-R interval appeared 2 to 3
beats after the end of the ramp of blood pressure. In all experiments,
animals were pretreated with the beta-adrenergic receptor antag-
onist, propranolol (100 mgk g
21) in order to avoid sympathetic
arrhythmogenic influences on heart responses. In some experi-
ments, the AchE inhibitor neostigmine (25 mgk g
21) was also
administered prior to PNE; in these experiments, PNE doses were
reduced to 250 mgk g
21. All drugs were injected intravenously.
At the end of in vivo experiments, rabbits were sacrificed with a
bolus injection of pentobarbital (50 mg kg
21) and the hearts were
removed. Tissue samples were stored at 220uC in 0.25 M
saccharose for radioligand binding experiments or immediately
frozen in liquid nitrogen and then stored at 280uC for AchE gene
expression measurements.
Radioligand binding experiments
Methods were adapted from Gies et al. [13,14]. All saturation
binding experiments were carried out at 25uC in 0.5 mL Tris buffer
(50 mM, pH 7.4) containing 50–70 mg protein. Heart samples were
incubated for 90 min. Incubation was stopped by rapid vacuum
filtration over Whatman GF/C glass microfibre filters (VWR
International SAS, Strasbourg, France) presoaked with polyethyle-
nimine 0.3% in order to reduce non-specific binding to the filters.
Filters were washed twice with 4 mL of ice-cold incubation buffer
and transferred to 6 mL counting vials containing 3 mL of
scintillation cocktail (Ready Protein+
TM, Beckman Coulter France
SA, Roissy CDG, France). Radioactivity was then counted in a
liquid scintillation spectrometer (LS 6000SC; Beckman Instru-
ments) with an efficiency of 45%. Scatchard analysis of the
saturation data (linear regression with Excel Software) was used to
yield the maximal specific binding sites (Bmax; fmol mg
21 protein).
Protein content was measured according to the method of Bradford
[15] using bovine c-globulin as standard.
The density of total muscarinic receptors was assessed using the
tritiated non-selective muscarinic receptor antagonist N-methyls-
copolamine ([
3H]NMS; 81.0 Ci mmol
21) added in 12 concentra-
tions ranging from 40 to 2000 pmol L
21. Non-specific binding was
determined in the presence of 1 mmol L
21 atropine. M1,M 2 and
M3 muscarinic receptors were selectively labelled using tritiated
pirenzepine ([
3H]PZ; 86.0 Ci mmol
21), AF-DX 384 ([
3H]AF-DX
384; 120.0 Ci mmol
21) and 4-diphenylacetoxy-N-methyl piperi-
dine methiodide ([
3H]4-DAMP; 80.1 Ci mmol
21), respectively
[16,17], all added in 12 concentrations ranging from 100 to
5000 pmol L
21. Nonspecific binding was determined in the
presence of 10 mmol L
21 atropine.
Preparation of peripheral mononuclear white blood cells
(PMBC)
Three ml of fresh blood samples from normal and vagal
hyperreactive rabbits were placed on 3 ml of HistopaqueH-1077
(Sigma-Aldrich, Saint-Louis, MO) and centrifuged at 1500 rpm for
30 min. The white mononuclear cell layer was taken and transferred to
tubes with 10 ml of 0.1 M sodium phosphate buffer pH 7.4 (PBS) and
centrifuged at 1800 rpm for 10 min. Mononuclear cells were
resuspended in 100 ml PBS and processed for total RNA extraction.
M2 receptor and AchE gene expression
Total RNA was extracted from PMBC samples using the
MagNA Pure Compact RNA Isolation Kit on a MagNA Pure
Compact Instrument (Roche, Basel, Switzerland) following the
manufacturer protocol instructions. One hundred and fifty ng of
total RNA were then reverse transcribed into cDNA using the
LightCyclerH Transcriptor First Strand cDNA Synthesis Kit
(Roche, Basel, Switzerland). Cardiac samples were homogenized
in QiazolH and RNA was extracted using QiagenH (QIAGEN
Inc., Valencia, CA) extract columns following the manufacturer’s
protocol instructions; 2 mg of total RNA were then reverse
transcribed into cDNA using the superscript reverse transcriptase
II (SSRII, Invitrogen Corp., France).
M2 and AchE gene expressions were measured by quantitative
real time polymerase chain reaction (Q-RT-PCR) using a
LightCyclerH amplifier and a fluorescent SybrGreen I dye for
detection (Roche, Basel, Switzerland) using specific primers for M2
receptors (forward 59GGCAGGAATGATGATTGCAGC39; re-
Table 1. Cardiac muscarinic receptors density and R-R interval duration in normal (N) and vagal hyperreactive (H) rabbits.
N rabbits H rabbits
Bmax
[fmol mg
21 protein]
R-R interval
[ms]
Bmax
[fmol mg
21 protein]
R-R interval
[ms]
Total M 157.6 (37.8) 1867 (615) 469.0 (185.5) 10644 (2633)
(n=6Nand9H) (P=0.001) (P,0.0001)
M2 65.6 (18.9) 2600 (783) 148.7 (72.6) 11560 (4339)
(n=7 N and 10 H) (P=0.01) (P,0.0001)
M3 88.6 (30.1) 2317 (939) 226.9 (77.3) 9960 (2954)
(n=6 N and 10 H) (P=0.001) (P,0.0001)
The severity of vagal pauses was evaluated in conscious animals by measuring the duration of R-R interval on the ECG recording after challenge with PNE 500 mgk g
21
following the procedure described in Material and Methods. Total, M2 and M3 muscarinic receptors densities (Bmax) in hearts from normal (N) and vagal hyperreactive (H)
rabbits were obtained from Scatchard analysis of the saturation data using [
3H]NMS (total), [
3H]AF-DX 384 (M2) and [
3H]4-DAMP (M3) as radioligands. Binding conditions
were as described in Material and Methods. Values are means (SD) of n independent experiments. P: H versus N within each group.
doi:10.1371/journal.pone.0015618.t001
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59CCCAAGAAAGCATCTTCCGCT39; reverse 59TGAGGG-
TACCTATTTTCTGG39), and the rabbit 18S housekeeping
gene (forward 59CGCGGTTCTATTTTGTTGGT39; reverse
59CGAAAGTCGGAGGTTTGAAG 39), used for normalization.
The cycling conditions were: 95uC for 10 min, then 45 cycles of
Figure 1. Correlations between R-R interval and total, M2 and M3 muscarinic receptor density in hearts from normal (N) and vagal
hyperreactive (H) rabbits. R-R intervals were measured in conscious rabbits challenged with PNE 500 mgk g
21 following the procedure described
in Material and Methods. Total, M2 and M3 muscarinic receptor densities in hearts (Bmax; fmol mg
21 protein) were determined from Scatchard analysis
of the saturation data using [
3H]NMS, [
3H]AF-DX 384 and [
3H]4-DAMP, respectively, as radioligands. Binding conditions were as described in Material
and Methods. Each symbol represents one animal. (a) Total muscarinic receptors; n=9 H (full symbols) and 6 N (open symbols). (b)M 2 muscarinic
receptors; n=10 H (full symbols) and 7 N (open symbols). (c)M 3 muscarinic receptors; n=10 H (full symbols) and 6 N (open symbols).
doi:10.1371/journal.pone.0015618.g001
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amplification products was assessed by melting curve analysis.
Relative M2 and AchE gene expressions were quantified using the
2
2DDCt method [18].
M2 receptor gene sequencing
GenomicDNAsfromnormalandvagalhyperreactiverabbitswere
isolatedfromperipheralbloodcellsusingQiagentechnology(GmbH,
Hilden, Germany) and quantified by spectrophotometry. Exon of the
cholinergic muscarinic M2 receptor gene (rabbit CHRM2, Ensembl
genome database) was amplified using specific primers (forward
59GGCAGGAATGATGATTGCAGC39 and reverse 59AGC-
TAGTTGGGTCTTCAGGTC39). All amplification reactions were
performed on a Mastercycler epgradient 5 (Eppendorf, France) using
a Taq DNA polymerase from Sigma (Sigma-Aldrich, Saint-Quentin,
France), 1.5 mMMgCl2and 500 nM of each primer in a PCR buffer
(Sigma-Aldrich, Saint-Quentin, France) under the following cycling
conditions: 94uC for 5 min, followed by 35 cycles of 30 s at 94uC,
20 s at 58uC, 15 s at 72uC. Quality of the amplification products was
checked by gel electrophoresis. After amplification, PCR products
were purified on QIAquick columns (Qiagen) and processed on an
AB 3100 genetic analyzer (Applied Biosystems, CA). After the
sequencing step, extension products were size-fractionated by
capillary electrophoresis and sequences were compared to the M2
receptor gene reference sequence from the Ensembl genome
database using SeqScape (Applied Biosystems, CA) and BioEdit (Ibis
Therapeutics, CA) softwares.
AchE enzyme activity
AchE enzyme activity was measured in erythrocytes from
venous total blood samples collected on heparin according to an
enzymatic colorimetric assay as previously described [19].
Ethics statement
All the methods employed in this work are in accordance with
the French law concerning experimentations on vertebrate
laboratory animals (De ´cret 2001-464 from May 29, 2001 as a
revision of the De ´cret 87-848, 1987) and according to European
guidelines. PB, JF and JPG hold personal agreements from the
Direction des Services Ve ´te ´rinaires du Bas-Rhin, Agriculture
Ministery, France (authorization numbers 67–249 to PB, 67-2010
to JF and 67–87 to JPG) which cover the protocols followed in the
present study.
Statistics
All values are expressed as mean 6 standard deviation (SD). SD
values were preferred to SEM since they better reflect variabilities
of the measured parameters than SEM values. Unpaired t-tests
were performed using the Mann-Whitney U test. P values , 0.05
were considered to be statistically significant.
Results
Haemodynamic effects of the standard dose of
phenylephrine
The severity of vagal pauses was evaluated in conscious
animals by measuring the duration of the R-R interval on
ECG recording after intravenous injection of a standard dose of
phenylephrine (PNE; 500 mgk g
21). The 500 mgk g
21 dose
of PNE increased mean blood pressure by 44611%
(124613 mmHg after PNE vs 8163 m m H ga tr e s t ) .M e a n
values of R-R interval duration after PNE challenge were
23396786 ms and 1070763421 ms in normal (N) and hyper-
reactive (H) rabbits, respectively.
Figure 2. M2 muscarinic receptor gene expression in peripheral mononuclear white blood cells from normal (N) and vagal
hyperreactive (H) rabbits. R-R intervals were measured in conscious rabbits challenged with PNE 500 mgk g
21 following the procedure described
in Material and Methods. M2 muscarinic gene expression was assessed in peripheral mononuclear white blood cells by quantitative RT-PCR and
normalized to the rabbit 18S housekeeping gene. Values in (a) show amplification ratio calculated according to the 2
2DDCt method of 9 (N) and 16 (H)
experiments. In (b), each symbol represents one animal; DCt M2-18S corresponds to the number of amplification cycles needed to detect M2
fluorescence standardized to 18S; thus, the lower the DCt M2-18S, the greater M2 mRNA initial quantity. *: P,0.0001 versus N.
doi:10.1371/journal.pone.0015618.g002
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correlation with the bradycardic response to
phenylephrine
In saturation binding experiments, a significant 2.5- to 3-fold
increase in the total density of muscarinic receptors (Bmax) labelled
by [
3H]NMS was observed in the heart of H rabbits as compared
to controls (Table 1). To further characterize the muscarinic
receptor sub-populations, M1,M 2 and M3 receptors were
selectively labelled using [
3H]PZ, [
3H]AF-DX 384 and [
3H]4-
DAMP, respectively. In the heart from rabbits with normal vagal
responses, M2 receptors represented 40 to 45% of the total, and
the remainder were M3; no expression of receptors of the M1-
subtype could be detected (n=3, data not shown). The densities of
both M2 and M3 receptors were significantly and significantly
enhanced in H rabbits as compared to N rabbits (2.3-fold and 2.5-
fold, respectively, Table 1).
The R-R interval duration was taken as a measure of the
bradycardic response to PNE. In H rabbits used for [
3H]NMS
binding experiments, the R-R interval durations, after injection of
PNE, ranged from 6500 to 15200 ms (mean 1064462633)
compared to N rabbits (1200 to 2800 ms; mean 18676615).
The 2.5- to 3-fold increase in the density of muscarinic receptors
was accompanied by a 4.5 to 5-fold increase in R-R duration
(Table 1). Within this group of animals, a highly significant
positive correlation was found between the R-R interval and the
total muscarinic receptor density (Fig. 1a); compared to the
control group, all values for receptor density (and consequently for
R-R interval) were shifted to higher levels.
Figure 3. AchE cardiac gene expression and enzyme activity in erythrocytes from normal (N) and vagal hyperreactive (H) rabbits. R-
R intervals were measured in conscious rabbits challenged with PNE 500 mgk g
21 following the procedure described in Material and Methods. (a,b)
Cardiac AchE gene expression was assessed by quantitative RT-PCR and normalized to the rabbit 18S housekeeping gene. Values in (a) show
amplification ratio calculated according to the 2
2DDCt method of 7 (N) and 10 (H) experiments. In (b), each symbol represents one animal; DCt AchE-
18S corresponds to the number of amplification cycles needed to detect AchE fluorescence standardized to 18S; thus, the lower the DCt AchE-18S,
the greater AchE mRNA initial quantity. (c) AchE enzyme activity was assayed colorimetrically in erythrocyte hemolysates from 7 (N) and 13 (H)
animals. *: P=0.008 versus N. **: P=0.02 versus N.
doi:10.1371/journal.pone.0015618.g003
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density of M2 and M3 receptors within the two respective groups
(range of R-R interval values from 5800 to 19600 ms, mean
1156064339, and from 6400 to 16000 ms, mean 996062954, for
animals used for M2 and M3 binding experiments, respectively)
(Fig. 1b,c). The slopes of the linear regressions differed markedly,
however, being almost 2-fold greater with M2 than M3, indicating
that a change in M2 receptor density influenced cardiac responses
much more than the same change in M3 receptor density. Thus, it
appears that vagal hyperreactivity can be considered a conse-
quence of the overexpression of cardiac M2 and M3 muscarinic
receptors.
Expression of muscarinic receptors in peripheral
mononuclear white blood cells
M2 mRNA expression level was about 10 times higher in vagal
hyperreactive rabbits compared to that observed in normal rabbits
(Fig. 2a). Compared to normal animals, M2 mRNA relative
quantities were increased in all rabbits displaying baroreflex
dysfunction and vagal hyperreactivity (Fig. 2b).
AchE gene expression and enzyme activity
In an attempt to better characterise vagal disorders in H rabbits,
we looked at whether AchE gene expression and enzyme activity
were also changed in these animals.
Vagal hyperreactive rabbits displayed an AchE mRNA amplifi-
cation ratio of 3.6 versus normal rabbits (Fig. 3a,b); this was
associated with twice the enzyme activity in erythrocytes (Fig. 3c).
When AchE was blocked by intravenous administration of
neostigmine, a specific AchE inhibitor, H rabbits displayed massively
increased bradycardia following PNE injection (up to 10-fold higher
in some individuals;Fig. 4). These data confirmed that AchE enzyme
activity was increased in the hearts of these animals. Taken together,
the findings showed up-regulation of AchE in H rabbits.
Evolution of vagal disorders with age
As a next step, age-dependent changes in vagal disorders and
their functional consequences on R-R intervals were assessed in
normal and hyperreactive rabbits. Blood samples were collected at
the ages of 5 and 7 weeks. The M2 expression decreased between
the 5th and the 7th week of age in rabbits with normal vagal
responses, whereas it remained unchanged in hyperreactive
animals (Fig. 5a). In contrast, the AchE expression remained
stable in N rabbits but increased significantly in H rabbits within
the same period (Fig. 5a). Consequently, the M2/AchE ratio was
similar whatever the age and the strain (Fig. 5a).
Functionnal disordersappeared after7 weeksofage:R-Rinterval
duration was similar in all rabbits up to 7 weeks and then increased
in H rabbits, while remaining stable in N animals (Fig. 5b). Despite
SD error-bars appear overlapping on this figure, data were
significantly different (P=0.0179 at 8–11 weeks and P=0.011 at
12–14 weeks compared to values observed at 7 weeks).
Mortality study
Mortality has been assessed in a population of 2150 normor-
eactive rabbits and 385 hyperreactive animals.
In hyperreactive animals, the altered changes in M2 muscarinic
receptor and AchE expression were associated with an abnormally
high mortality rate between 5 to 7 weeks of age: 52% in H rabbits
versus 13% in normal rabbits. Mortality was higher in male than
female (57% versus 43%). In most cases, diarrhea and digestive
dysfunctions were observed shortly before death.
M2 receptor gene sequencing
After sequencing the cholinergic receptor M2 gene, we detected a
single nucleotide mutation from thymine to guanine (TRG) in position
1311 (Fig. 6a). This mutation transformed the normal CCT codon
into CCG, both encoding for the proline amino-acid. The two codons
were not equally distributed among animals. Over the 46 rabbits
tested, 17 had the wild genotype CCT/CCT, 12 were heterozygous
CCT/CCG and 17 were homozygous CCG/CCG. None of the 11
normal rabbits had the mutation, while it was present in 29/35, i.e.,
83% of the vagal hyperreactive rabbits (Fig. 6b). The mean R-R
interval in normal rabbits was 331861336 ms; mean R-R intervals in
hyperreactive rabbits were 2470066855 ms (wild genotype CCT/
CCT), 1665066572 ms (heterozygous CCT/CCG) and 210966
7759 ms (homozygous CCG/CCG) (Fig. 6b).
Discussion
In a previous study [12], we showed that spontaneous vagal pauses
were observed in a particular strain of adult rabbits (12–14 weeks of
Figure 4. Effect of AchE enzyme blockade in normal (N) and vagal hyperreactive (H) rabbits. R-R intervals were measured in conscious
rabbits challenged with PNE 250 mgk g
-1 before (control) and after administration of neostigmine 25 mgk g
21. Values are means 6 SD of 4 N and 4 H
experiments. *: P=0.02 versus N control; **: P=0.03 versus H control.
doi:10.1371/journal.pone.0015618.g004
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PLoS ONE | www.plosone.org 6 December 2010 | Volume 5 | Issue 12 | e15618Figure 5. Age-dependent changes in R-R interval and M2 muscarinic receptor and AchE gene expression in peripheral mononuclear
white blood cells from normal (N) and vagal hyperreactive (H) rabbits. (a)M 2 muscarinic receptor and AchE gene expression were assessed
in peripheral mononuclear white blood cells by quantitative RT-PCR and normalized to the rabbit 18S housekeeping gene. Values show amplification
ratio calculated according to the 2
2DDCt method of 8–9 (N) and 7–11 (H) experiments. *: P=0.0262 and **: P=0.0122 versus 5 weeks-old rabbits within
the N and the H group, respectively. (b) R-R intervals were measured in conscious rabbits challenged with PNE 500 mgk g
21 following the procedure
described in Material and Methods. Values are means 6 SD of 11 N and 15 H rabbits. *: P=0.0179 and **: P=0.0110 versus 7 weeks-old rabbits within
the H group.
doi:10.1371/journal.pone.0015618.g005
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hyperreactivity. In the experimental conditions of the present study,
the PNE test was used to screen hyperreactive animals. To prevent
sudden death due to arrhythmogenic complications of PNE, the
animalswere treated with the b-blocking drug, propranolol.A unique
bolus dose of the latter was delivered shortly before the PNE test. As
shown previously, maximal R-R interval is a reliable index to assess
the vagal reactivity in these animals [12].
In binding experiments, we showed that the densities of both
M2 and M3 muscarinic receptors were enhanced in the heart of
rabbits displaying exacerbated vagal responses. A similar increase
of M2 mRNA was observed in peripheral mononuclear white
blood cells. As the sequence of the M3 receptor gene was not
known, PCR experiments regarding mRNA expression could not
be performed. A significant correlation was established between
the severity of the bradycardia and the cardiac muscarinic
receptor expression level indicating that vagal hyperreactivity
was highly dependent on muscarinic receptor density. The
increase in the M2 subtype is in line with the well-established
negative chronotropic effects of these receptors. We also found a
Figure 6. Polymorphism of the M2 cholinergic muscarinic receptor gene of normal (N) and vagal hyperreactive (H) rabbits. (a) DNA
sequence analysis of the coding fragment of the M2 muscarinic receptor gene (Chmr2) showing the normal CCT codon and the single nucleotide
substitution at position 1311 (G instead of T). (b) The severity of vagal pauses was evaluated in conscious animals by measuring the duration of R-R
interval on the ECG recording after challenge with PNE 500 mgk g
21 following the procedure described in Material and Methods. DNA sequence
analysis of the coding fragment of the M2 muscarinic receptor gene was carried out as described in Material and Methods. Each symbol represents
one animal.
doi:10.1371/journal.pone.0015618.g006
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been identified in hearts of several mammalian species, including
humans [16,20–22], and recent studies showed that M3 stimula-
tion mediates K
+ currents in cardiac cells [23,24]. Interestingly, no
overlap between the muscarinic receptor expression in normal and
diseased animals was observed and muscarinic receptor overex-
pression was detected in all hyperreactive animals, suggesting
that it is a primary cardiac abnormality underlying vagal
hyperreactivity.
Compared to control animals, bradycardia after PNE challenge
was unexpectedly accentuated upon AchE blockade by neostig-
mine in hyperreactive rabbits. This result suggested an increase of
AchE activity in the heart of H rabbits. In fact, in about 50–60%
of vagal hyperreactive rabbits, overexpression of muscarinic
receptors was associated with an increase in expression of the
AchE gene in the heart and in enzyme activity in erythrocytes.
This increase of AchE expression and activity appears at first
glance paradoxical. Looking at individual data, while no overlap
between Bmax values obtained from H rabbits compared with
controls was observed, there was some overlap for AchE
expression and activity. Indeed, two groups of H rabbits were
identified: a first one which displayed enhanced AchE levels, and a
second one which did not. Taken together, these results indicate
that the primary cardiac abnormality is in fact the overexpression
of muscarinic receptors whereas AchE upregulation appears as a
possible compensatory consequence of the latter.
Data of the maturation studies are in agreement with this
assumption. Thus, muscarinic receptor expression remains stable
between 5 and 7 weeks of age in hyperreactive rabbits while it is
largely downregulated in normal rabbits. The concomittent
increase in AchE level in hyperreactive animals may be a
compensatory process opposing the functional consequences of
the high muscarinic receptor expression to maintain the M2/AchE
ratio. These alterations in H rabbits occurred at a very specific age
(between the 5th and the 7th week after birth), at which
abnormally high mortality was also observed. Therefore, stability
of the M2/AchE ratio appears as the key determinant of survival at
least at the age of 7 weeks. Further studies will establish whether
the M2/AchE ratio is actually modified in deceased offsprings of H
rabbits. If this were also true in SIDS, muscarinic receptor
overexpression would be the link between vagal hyperreactivity
and SIDS. We would then have come full circle.
Of note, similar patterns of changes were found whether M2
receptor expression and AchE levels were assessed in cardiac tissue
or in blood cells, in which muscarinic receptors and AchE are
known to be expressed [25–27]. Thus, it appears that cardiac
abnormalities can be inferred with high confidence from M2
muscarinic receptor and AchE expression measurements in easily
accessible blood cells, which may be of great practical interest. At
least in our animal model, the muscarinic receptor expression level
in peripheral mononuclear white blood cells appears as a reliable
and easily measurable marker of vagal hyperreactivity and
baroreflex dysfunctions.
Further investigations are needed to determine whether
muscarinic receptors are also overexpressed in peripheral
mononuclear white blood cells from patients with vagal syncopes
and from SIDS – as observed in rabbits. If so, muscarinic receptor
expression level in peripheral mononuclear white blood cells could
become a reliable and easily measurable marker of risk among
subjects exhibiting vagal or vasovagal syncopes, which could be of
great clinical interest.
We previously demonstrated that inheritance of the vagal
disorder in our rabbit experimental model is polygenic with a
partial sex-limited character [12]. We therefore sought for a
mutation on the muscarinic M2 receptor gene and indeed
identified a single nucleotide mutation in the coding fragment of
the M2 muscarinic receptor gene of 83% of the vagal
hyperreactive rabbits. However, the mutation from a CCT into
a CCG codon does not change the amino-acid sequence since
both codons encode for the same amino-acid, i.e., proline, and
may then induce a quantitative rather than qualitative alteration in
the M2 gene. Such a TRG mutation could create an exonic
splicing enhancer site (ESE), interacting with the SF2/ASF
splicing factor, and could simultaneously delete another ESE
interacting with the SC35 splicing factor [28,29]. ESE sequences
are known to facilitate splicing through their interactions with
various proteins [30]. The appearance of a new splicing site could
lead to a qualitatively different gene product or, maybe more
relevant in our model, to the overexpression of normal transcripts
[31]. In agreement with the latter assumption, it is remarkable that
the density in muscarinic receptors is much higher in rats, in which
the reference codon sequence is CCG, compared to human and
rabbits, in which the reference codon sequence is CCT [32].
In conclusion, we showed that overexpression of cardiac
muscarinic receptors may play a critical role in the development
of vagal hyperreactivity. The average AchE activity and expression
were also increased in hyperreactive rabbits compared to controls,
which could represent an attempt to oppose the increased
muscarinic receptor density in order to maintain the sympatho-
vagal balance. A same pattern of changes was detected in
peripheral mononuclear white blood cells. Thus, in our animal
model, muscarinic abnormalities in cardiac tissues could be
inferred with high confidence from those measured in lympho-
cytes. Finally, vago-cardiac abnormalities detected in tissues from
hyperreactive animals were similar to those detected in the hearts
of SIDS. Altogether, these data raise the possibility that muscarinic
receptor expression level in peripheral mononuclear white blood
cells could become a reliable and easily measurable marker of risk
of vasovagal syncopes and sudden death.
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